Orizuru Therapeutics - Ownership and Business Overview

Life ScienceCompany

Orizuru Therapeutics Ownership

Who owns Orizuru Therapeutics?

Orizuru Therapeutics is owned by Nomura Holdings. It was acquired on February 29, 2024.

Orizuru Therapeutics Business Overview

Where is Orizuru Therapeutics headquartered?

Orizuru Therapeutics is headquartered in Kanagawa, Japan.

What sector is Orizuru Therapeutics in?

Orizuru Therapeutics is a life science company.

Life Science M&A Summary in 2024

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.

Join Mergr to view all 201 acquisitions of life science companies in 2024, including 20 acquisitions by private equity firms, and 181 by strategics.

Orizuru Therapeutics

Orizuru Therapeutics, Inc.

Shonan Health Innovation Park, 2-26-1 Muraoka-higashi,Fujisawa-shi,
Kanagawa, 251-8555
Japan,
www.orizuru-therapeutics.com

Orizuru Therapeutics is an R&D driven company focusing on the development of iPS cell-based regenerative medicine and the application of iPS cell technologies. Orizuru Therapeutics is based in Kanagawa, Japan.


 Subscribe to unlock this and 208,848
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Orizuru Therapeutics

Life Science Companies , Japan Companies